11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male and female - 21.8 mg/kg (OECD Test Guideline 401)
LD50 Oral - 5.1 mg/kg
LC50 Inhalation - Rat - 4 h - 0.037 mg/l - dust/mist (OECD Test Guideline 403)
LD50 Dermal - Rat - 177 mg/kg (OECD Test Guideline 402)
Skin corrosion/irritation
Skin - Rabbit
Result: slight irritation - 4 h (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Mild eye irritation (OECD Test Guideline 405)
Respiratory or skin sensitization
Sensitisation test (Magnusson and Kligman): - Guinea pig
Result: negative (OECD Test Guideline 406)
Germ cell mutagenicity
Test Type: Ames test
Test system: Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Ames test
Test system: Escherichia coli
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Test system: mouse lymphoma cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 476
Result: negative
Test Type: Chromosome aberration test in vitro
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Test Type: Chromosome aberration test in vitro
Species: Rat
Cell type: Bone marrow
Application Route: Gavage
Method: OECD Test Guideline 475
Result: negative
Test Type: Chromosome aberration test in vitro
Species: mice
Cell type: Bone marrow
Application Route: Oral
Method: OECD Test Guideline 474
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 90 d - No observed adverse effect level - 13.6 mg/kg
Remarks: Subchronic toxicity
Repeated dose toxicity - Rat - Dermal - 21 d - No observed adverse effect level - 50 mg/kg - Lowest observed adverse effect level - 0.1 mg/kg
Remarks: Subacute toxicity
RTECS: GZ1227850
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.